Related Experiment Video

Updated: Mar 30, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in

Manish Neupane1, Allison P Clark1, Serena Landini2

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Cancer Discovery
|November 8, 2015
PubMed
Abstract

Insights

Methyl cytosine-guanine dinucleotide binding protein 2 (MECP2) is identified as a novel oncogene. Amplified MECP2 drives cancer growth via epigenetic pathways, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Genome-wide screens reveal novel cancer drivers.
  • Overexpression of specific genes can promote tumor growth.
  • Understanding oncogene mechanisms is crucial for cancer therapy.

Purpose of the Study:

  • To identify novel oncogenes driving cancer growth through overexpression.
  • To elucidate the mechanism of action for newly identified oncogenes.
  • To investigate the role of MECP2 in cancer development and progression.

Main Methods:

  • Unbiased genome-scale screening for overexpressed oncogenes.
  • Analysis of gene copy number and expression in cancer datasets.
  • Functional assays to assess MECP2's role in cell proliferation and pathway activation.
  • Investigation of MECP2's interaction with epigenetic modifications.

Main Results:

  • Methyl cytosine-guanine dinucleotide binding protein 2 (MECP2) identified as a novel oncogene.
  • MECP2 amplification observed in 18% of cancers, with dependency in cell lines.
  • MECP2 isoforms activate MAPK and PI3K pathways, mimicking RAS signaling.
  • MECP2-RAS pathway interactions are mutually exclusive, suggesting distinct roles.
  • MECP2's epigenetic binding to 5-hydroxymethylcytosine is essential for transformation.

Conclusions:

  • MECP2 is a commonly amplified oncogene in human cancers.
  • MECP2 possesses a unique epigenetic mechanism of action.
  • Findings suggest MECP2 as a potential therapeutic target in specific cancers.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

909

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K